Clinical Trials
4
Active:0
Completed:4
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
Not Applicable
Completed
- Conditions
- Actinic Keratoses
- Interventions
- Drug: Vehicle Cream
- First Posted Date
- 2011-12-30
- Last Posted Date
- 2011-12-30
- Lead Sponsor
- Actavis Mid-Atlantic LLC
- Target Recruit Count
- 410
- Registration Number
- NCT01502020
- Locations
- 🇺🇸
Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States
🇺🇸International Dermatology Research, Inc., Miami, Florida, United States
🇺🇸MedaPhase, Inc., Newnan, Georgia, United States
A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris
Not Applicable
Completed
- Conditions
- Acne Vulgaris
- Interventions
- First Posted Date
- 2011-12-29
- Last Posted Date
- 2011-12-29
- Lead Sponsor
- Actavis Mid-Atlantic LLC
- Target Recruit Count
- 885
- Registration Number
- NCT01501799
- Locations
- 🇺🇸
Center for Dermatology Clinical Research Inc., Fremont, California, United States
🇺🇸FXM Research Corp., Miami, Florida, United States
🇺🇸FXM Research Miramar, Miramar, Florida, United States
Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo
Not Applicable
Completed
- Conditions
- MILD TO SEVERE ACNE VULGARIS
- Interventions
- First Posted Date
- 2010-12-10
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- Actavis Mid-Atlantic LLC
- Target Recruit Count
- 1225
- Registration Number
- NCT01257906
- Locations
- 🇮🇳
Lotus Labs Pvt. Ltd, Bangalore, India
Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel
- First Posted Date
- 2010-03-30
- Last Posted Date
- 2010-03-30
- Lead Sponsor
- Actavis Mid-Atlantic LLC
- Target Recruit Count
- 1159
- Registration Number
- NCT01095640
- Locations
- 🇮🇳
L.T.M. Medical College & General Hospital, Mumbai, India
News
No news found